IM Cannabis Corp.

US$0.64As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IMCCHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (73.93%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 2.55
PE TTM —
TSR TTM (98.52%)
Mkt cap US$1.051M
ROIC (68.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.69
8.16%
(78.64%)
Hold 5|9|6|1|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
(2.91%)
(4.71%)
(6.22%)
(1.58%)
Revenue$M
0.052
0.053
0.054
0.057
5.25%
6.69%
12.09%
14.87%
Peers (US$1.051M)
Cap (US$)
PE
1.268M
—
1.096M
—
Capital
TTM
5Y
10Y
Leveragex
0.455
0.403
0.408
EBIT/Intx
1.944
0.042
0.047
Own earn%
108.88
(8.57)
(20.60)
Sh yield%
52.51
7.87
6.56
Owners
Insiders/Inst%
13.23
85.29
Short interest%
4.68
SBC / revenue%
0.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
11–17
$1 testx
0.0
Incr. ROIC%
2